Adherent cells in granulocyte-macrophage colony-stimulating factor-induced bone marrow-derived dendritic cell culture system are qualified dendritic cells

Cellular Immunology

Volumn 264, Issue 1, 2010, Pages 4-6

  Li, Gong Bo ^a   Lu, Guang Xiu ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adherent cell; Bone marrow; Dendritic cell

Indexed keywords

CD11 ANTIGEN; CD86 ANTIGEN; CELL SURFACE MARKER; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADHERENT CELL; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL FUNCTION; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; MACROPHAGE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BONE MARROW; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL SEPARATION; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

EID: 77954144488     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.05.009     Document Type: Article

References (7)

1. Inaba K., Romani N., Schuler G., Mirza A., Steinman R.M. Generation of dendritic cells from proliferating mouse bone marrow progenitors. Current Protocols in Immunity 1998, Wiley, New York, [Unit 3.7.]. R. Coico, A. Ranz, A.M. Kruisbeek (Eds.).
2. Lutz M.B., Kukutsch N., Ogilvie A.L., Röβner S., Koch F., Romani N., et al. An advanced culture method for generation large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999, 223:77-92.
3. Chen Z., Huang H., Chang T., Carlsen S., Saxena A., Marr R., et al. Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor. Cancer Gene Therapy 2002, 9:778-786.
4. Sakai Y., Morrison B.J., Burke J.D., Park J.M., Terabe M., Janik J.E., et al. Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice. Cancer Research 2004, 64:8022-8028.
5. Chan T., Sami A., El-Gayed A., Guo X., Xiang J. HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination. Gene Therapy 2006, 13:1391-1402.
6. Li G.B., Lu G.X. Gene delivery efficiency in bone marrow-derived dendritic cells: comparison of four methods and optimization for lentivirus transduction. Mol Biotechnol. 2009, 43:250-256.
7. Nuñez R. Assessment of surface markers and functionality of dendritic cells (DCs). Current protocols in Cytometry 2001, 9-17. John Wiley & Sons, New York. J.P. Robinson (Ed.).